By analyzing the formation of peptides from treatment of tetanus toxoid by recombinant human cathepsin S, an important enzyme involved in antigen processing in vivo, aberrant tetanus toxoids could be distinguished from control toxoids. This evidence concerns the gene CTSS and tetanus.